Trial record 1 of 7 for:    "Dent disease"
Previous Study | Return to List | Next Study

Dent Disease Mutation Genotyping

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Mayo Clinic
Sponsor:
Information provided by (Responsible Party):
John Lieske, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01783795
First received: January 23, 2013
Last updated: May 22, 2014
Last verified: May 2014
  Purpose

This study will help the investigator determine whether certain genetic mutations, more than others, are a cause of more severe disease in Dent Disease.


Condition Intervention
Dent Disease
Genetic: Genetic Analysis

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Screening
Official Title: Screening for Dent Disease Mutations in Patients With Proteinuria

Resource links provided by NLM:


Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • To determine which genetic mutations are the cause of a more severe disease, in Dent Disease. [ Time Frame: 4 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 602
Study Start Date: August 2012
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Genetic Analysis
Genetic Analysis
Genetic: Genetic Analysis

Detailed Description:

During this study visit, the investigator will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from your arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. We will use the isolated DNA to try to identify the gene that is defective in Dent Disease by comparing it with the structure of genes in normal individuals, patients with Dent Disease, and family members for Dent Disease.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • The patient has been diagnosed, or in the process of being diagnosed with Dent Disease.
  • You have a family member diagnosed with Dent Disease.

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01783795

Contacts
Contact: Barbara M Seide 507-255-0387 seide.barbara@mayo.edu
Contact: Mayo Clinic Hyperoxaluria Center 800-270-4637 hyperoxaluriacenter@mayo.edu

Locations
United States, Minnesota
Mayo Clinic Recruiting
Rochester, Minnesota, United States, 55905
Contact: Barbara M Seide    507-255-0387    seide.barbara@mayo.edu   
Contact: Mayo Clinic Hyperoxaluria Center    800-270-4637    hyperoxaluriacenter@mayo.edu   
Principal Investigator: John C Lidske, MD         
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: John C. Lieske, MD Mayo Clinic
  More Information

Additional Information:
No publications provided

Responsible Party: John Lieske, M.D., Mayo Clinic
ClinicalTrials.gov Identifier: NCT01783795     History of Changes
Other Study ID Numbers: 10-006442
Study First Received: January 23, 2013
Last Updated: May 22, 2014
Health Authority: NIH: Data Safety Monitoring Board

Keywords provided by Mayo Clinic:
Dent
Dents
Dent Disease
Dent genetic testing
CLCN5
OCRL1
Genetic testing for Dent Disease
Hereditary study for Dent Disease

Additional relevant MeSH terms:
Dent Disease
Renal Tubular Transport, Inborn Errors
Kidney Diseases
Urologic Diseases
Genetic Diseases, X-Linked
Genetic Diseases, Inborn
Metabolism, Inborn Errors
Metabolic Diseases

ClinicalTrials.gov processed this record on July 23, 2014